Tag: Cancer: Bladder
Factors ID’d for Recurrence After Radical Cystectomy
Pathological tumor characteristics mainly predict recurrence after robot-assisted radical cystectomy
Study Looks at Recurrence After Laparoscopic Radical Cystectomy
During first 24 months, 8.7 percent of patients with favorable pathological characteristics had progressed
Sex Disparities in Chemo Use for Advanced Bladder Cancer
Women have lower median overall survival, even after adjustment for administration of chemo
Patient Experience Linked to Urologic CA Surgical Outcomes
Less prolonged hospitalization, fewer nursing-sensitive complications in high-performing hospitals
ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
Well Water a Suspected Cause of Bladder Cancer in New England
Researchers believe arsenic exposure might contribute to higher-than-normal rates
Optimally Timed Follow-Up Cuts Readmissions After Cystectomy
Timing, frequency of outpatient care helps identify concerning symptoms following radical cystectomy
Pioglitazone Linked to Increased Risk of Bladder Cancer
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone
ASCO Endorses European Guideline on Bladder Cancer
Guideline on muscle-invasive and metastatic bladder cancer, with qualifying statements
